Funding
← Back to your selection

Omega Funds

Activity from announced rounds

Activity in this selectionUnited States · Jan 31, 2026 · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$104.5M
2 disclosed · full round size, not this investor’s share

By stage

Series A2

By primary sector

Biotech1
Healthtech1

By country

United States2

Rounds

2 in this selection
Spiro Medical

Develops a Pulmonary Neuromodulation System for asthma treatment

$67MSeries A
Role not disclosed